MCF7 In Vitro Lactate Assay (Angiogenesis) (CAT#: ITS-1022-YF1313)

MCF7

Human

MCF-7 is a breast cancer cell line isolated in 1970 from a 69-year-old White woman. MCF-7 is the acronym of Michigan Cancer Foundation-7, referring to the institute in Detroit where the cell line was established in 1973 by Herbert Soule and co-workers. MCF7 are epithelial cells isolated from the breast tissue of a 69-year-old, White, female patient with metastatic adenocarcinoma. Use these cells in your breast cancer research.

MCF-7

Breast Adenocarcinoma

Oncology

In Vitro Lactate Assay (Angiogenesis)

MCF7-cell based In Vitro Lactate Assay (Angiogenesis)

Accumulation of lactate in cancer cells has been linked with poor survival and cancer metastasis. Higher glucose uptake in cancer cells is considered as the main cause for the accumulation and secretion of lactate by cancer cells. The lactate/pyruvate ratio is an essential parameter for the maintenance of the redox state of cells. Therefore, evaluation of cellular lactate levels allows assessment of the cellular oxygen utilization and demand. A number of commercially available colorimetric or fluorometric kits have been developed to detect lactate levels in cells and tissues.

Angiogenesis Monitoring Assays

Local and regional metastasis is a life-threatening condition in cancer, which is hard to control with the available cancer treatment options. In metastasis, cancer cells move away from primary tumors and travel through the blood and lymphatic system and form new tumors on other parts. A vascular
network growth is important for cancer metastasis. Angiogenesis is a process that is known as the formation of new blood vessels with the help of existing blood vessels and angiogenesis has been reported to play a major role in cancer growth and metastasis. Tumors can send chemical signals to nearby normal tissues to stimulate angiogenesis. New blood vessels can feed growing tumors with nutrients and oxygen, allowing cancer cells to spread (metastasis).